Fortitude Family Office »

Kala Pharmaceuticals shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Kala Pharmaceuticals shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Kala Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kala Pharmaceuticals held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kala Pharmaceuticals by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $393 709 0.56

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Apple Stock (AAPL)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Mid-cap Etf Etf (VO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Ishares Core S&p Mid-cap Etf Etf (IJH)

View all positions for Fortitude Family Office

Top funds holding Kala Pharmaceuticals

Fortitude Family Office
Chevoit Value Management
Parallel Advisors

View all funds holding Kala Pharmaceuticals